Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-24-139789·Pyxis Oncology, Inc.
Schedule 13D ownership disclosure
PYXIS ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 747324101
Event date: 2024-12-23
- Filing-level shares
- 6,624,699
- Percent of class
- 10.3%
- Lara SullivanReported CIK 0001769457
Shares: 6,624,699 · Class: 10.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-139789
- Form type
- SCHEDULE 13D/A
- Filer
- Pyxis Oncology, Inc.
- CIK
- CIK 1782223
- Filed
- Dec 23, 2024
- Reporting period
- Dec 23, 2024
- Description
- Schedule 13D beneficial ownership